Research Paper Volume 16, Issue 7 pp 6163—6187

KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer


Figure 4. The area under the curve of ROC curves verified the diagnostic ability of KIF3C in BLCA, CHOL, ESCA, ESAD, ESCC, GBM, GBMLGG, HNSC, KICH, LUSC, PRAD, SARC, SKCM and OSCC.